Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Provectus Biopharmaceuticals Inc (NYSE MKT LLC:PVCT)

0.3096
Delayed Data
As of Jul 22
 -0.0101 / -3.16%
Today’s Change
0.25
Today|||52-Week Range
0.70
-20.62%
Year-to-Date
Largest transactions by value over  
NameTypeDateShares
traded
Share
price
Transaction
value
Since
transaction
Wachter Eric A
Chief Technology Officer
Buy3/29/2016200,947$1.00$200.9K-16.91%
Culpepper Peter R
Buy3/29/2016133,333$1.00$133.3K-16.91%
Culpepper Peter R
Chief Financial & Operating Officer
Buy12/09/2015138,831$0.94$130.5K-32.70%
Koe Jan E
Director
Buy3/29/2016100,000$1.25$125.0K-16.91%
Koe Jan E
Director
Buy3/29/2016100,000$1.25$125.0K-16.91%
Wachter Eric A
Chief Technology Officer
Buy12/21/2015120,000$1.02$122.4K-21.62%
Wachter Eric A
Chief Technology Officer
Buy3/29/2016106,000$1.00$106.0K-16.91%
Culpepper Peter R
Buy3/29/2016106,000$1.00$106.0K-16.91%
Culpepper Peter R
Buy3/29/201627,333$1.00$27.3K-16.91%
Culpepper Peter R
Chief Financial & Operating Officer
Buy12/09/20156,383$0.94$6.0K-32.70%